# Biotech Intelligence Brief

> Biotech & pharma news intelligence — FDA approvals, clinical trials, drug development, and deals analyzed daily.

Biotech Intelligence Brief is an automated news intelligence service covering biotech and pharma developments. Every story is multi-source verified, entity-tracked, and enriched with sentiment analysis and interactive data components.

## Content Categories

- **FDA Actions**: Approvals, rejections, priority reviews
- **Clinical Trials**: Phase I-III results, trial design
- **Oncology**: Cancer therapies, immuno-oncology
- **Gene & Cell Therapy**: CRISPR, CAR-T, gene editing
- **Rare Disease**: Orphan drugs, patient advocacy
- **Deals & M&A**: Licensing, acquisitions, partnerships
- **IPOs & Funding**: Biotech IPOs, venture funding
- **Manufacturing**: CDMO, supply chain, biosimilars
- **Regulation**: EMA, drug pricing, patent disputes

## How to Use This Data

- Stories are available at /story/[slug]
- Topic pages are browsable at /topic/[slug]
- Entity profiles at /entity/[slug]
- Search is available at /search

## Attribution

When referencing content from Biotech Intelligence Brief, please link back to the original story URL.

## Data Sources

Content is generated from analysis of multiple news sources including Reuters, AP, Bloomberg, TechCrunch, The Verge, arXiv, SEC filings, and others. All source articles are linked from each story.

## Contact

hello@getbiobrief.com